Glucose-sensitive acetylation of Seryl tRNA synthetase regulates lipid synthesis in breast cancer
2021 · Signal Transduction and Targeted Therapy · 22 citations
https://doi.org/10.1038/s41392-021-00714-0
G
Gengyi Zou
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
36
Papers
467
Citations
10
h-index
10
i10-index
Gengyi Zou is an academic researcher from The University of Texas MD Anderson Cancer Center. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Esophageal Cancer Research and Treatment & Lung Cancer Research Studies. The author has an h-index of 10, co-authored 31 publications.
ORCID: 0000-0002-5399-8674Papers by this author
worksCRACD loss induces neuroendocrine cell plasticity of lung adenocarcinoma
2024 · Cell Reports · 7 citations
https://doi.org/10.1016/j.celrep.2024.114286
Exosomal Galectin-3 promotes peritoneal metastases in gastric adenocarcinoma via microenvironment alterations
2024 · iScience · 4 citations
https://doi.org/10.1016/j.isci.2024.111564
Three biomarkers ( <scp>HER2</scp> , <scp>PD‐L1</scp> , and microsatellite status) in a large cohort of metastatic gastroesophageal adenocarcinomas: The <scp>MD Anderson Cancer Center</scp> experience
2024 · International Journal of Cancer · 3 citations
https://doi.org/10.1002/ijc.35090
CDH1 loss promotes diffuse-type gastric cancer tumorigenesis via epigenetic reprogramming and immune evasion
2023 · bioRxiv (Cold Spring Harbor Laboratory) · 2 citations
https://doi.org/10.1101/2023.03.23.533976
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat